2010Zhongguo yiyuan ganranxue zazhiRequires access

Hospital-acquired pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a clinical analysis.

Xiangqun Fang

Open publisher page 0 citations

Abstract

OBJECTIVE To summarize the clinical characteristics of pneumonia caused by carbapenem-resistant Acinetobacter baumannii and explore therapeutical methods.METHODS The clinical data and antibiotic susceptibility tests of 12 cases were reviewed.RESULTS Pneumonia caused by carbapenem-resistant A.baumannii occurred in patients complicated with other diseases.X-rays showed bilateral infiltration in lungs.Totally 12 strains were resistant to both imipenem and meropenem.The susceptibility rate to polymyxin B was 75%.The resistant rate to cefoperazone/sulbactam was 50%,however,the intermediate rate was also 50%.Patients were treated with cefoperazone/sulbactam.Ten patients were improved and still in survival,2 patients were died within one month.CONCLUSIONS Cefoperazone/sulbactam shows therapeutical effect in the treatment for hospital-acquired pneumonia caused by carbapenem-resistant A.baumannii.

About this research paper

What this paper is about

OBJECTIVE To summarize the clinical characteristics of pneumonia caused by carbapenem-resistant Acinetobacter baumannii and explore therapeutical methods.METHODS The clinical data and antibiotic susceptibility tests of 12 cases were reviewed.RESULTS Pneumonia caused by carbapenem-resistant A.baumannii occurred in patients complicated with other diseases.X-rays showed bilateral infiltration in lungs.Totally 12 strains were resistant to both imipenem and meropenem.The susceptibility rate to polymyxin B was 75%.The resistant rate to cefoperazone/sulbactam was 50%,however,the intermediate rate was also 50%.Patients were treated with cefoperazone/sulbactam.Ten patients were improved and still in survival,2 patients were died within one month.CONCLUSIONS Cefoperazone/sulbactam shows therapeutical effect in the treatment for hospital-acquired pneumonia caused by carbapenem-resistant A.baumannii.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To summarize the clinical characteristics of pneumonia caused by carbapenem-resistant Acinetobacter baumannii and explore therapeutical methods.METHODS The clinical data and antibiotic susceptibility tests of 12 cases were reviewed.RESULTS Pneumonia caused by carbapenem-resistant A.baumannii occurred in patients complicated with other diseases.X-rays showed bilateral infiltration in lungs.Totally 12 strains were resistant to both imipenem and meropenem.The susceptibility rate to polymyxin B was 75%.The resistant rate to cefoperazone/sulbactam was 50%,however,the intermediate rate was also 50%.Patients were treated with cefoperazone/sulbactam.Ten patients were improved and still in survival,2 patients were died within one month.CONCLUSIONS Cefoperazone/sulbactam shows therapeutical effect in the treatment for hospital-acquired pneumonia caused by carbapenem-resistant A.baumannii.

Key concepts: Cefoperazone, Acinetobacter baumannii, Meropenem, Sulbactam, Medicine, Carbapenem, Imipenem, Pneumonia

Related papers

Back to paper searchBrowse research topicsOriginal source
Hospital-acquired pneumonia caused by carbapenem-resistant Acinetobacter baumannii: a clinical analysis. — Research Paper | ScholarLens